|
ABHD13 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.52299999570616E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.158610E-04 |
| Normal-vs-Stage2 |
2.587500E-02 |
| Normal-vs-Stage3 |
3.56120000044591E-07 |
| Normal-vs-Stage4 |
4.54949999895149E-08 |
| Stage1-vs-Stage2 |
8.501000E-01 |
| Stage1-vs-Stage3 |
3.461700E-02 |
| Stage1-vs-Stage4 |
1.983520E-03 |
| Stage2-vs-Stage3 |
2.483400E-01 |
| Stage2-vs-Stage4 |
1.109000E-01 |
| Stage3-vs-Stage4 |
4.415400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.25349999999547E-07 |
| Normal-vs-AfricanAmerican |
8.12450000053921E-07 |
| Normal-vs-Asian |
6.905900E-02 |
| Caucasian-vs-AfricanAmerican |
1.131610E-01 |
| Caucasian-vs-Asian |
7.867600E-01 |
| AfricanAmerican-vs-Asian |
7.919800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.95880000395132E-08 |
| Normal-vs-Female |
3.56059999999658E-05 |
| Male-vs-Female |
1.510350E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.55973000000031E-05 |
| Normal-vs-Age(41-60Yrs) |
2.40019999999674E-05 |
| Normal-vs-Age(61-80Yrs) |
2.79359999999507E-06 |
| Normal-vs-Age(81-100Yrs) |
5.901200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.287650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.811600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.499800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.463400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.981400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.182800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.344000E-01 |
| Normal-vs-Grade 2 |
4.880400E-03 |
| Normal-vs-Grade 3 |
9.92980000447119E-08 |
| Normal-vs-Grade 4 |
8.57209969673534E-10 |
| Grade 1-vs-Grade 2 |
8.140800E-01 |
| Grade 1-vs-Grade 3 |
3.861700E-02 |
| Grade 1-vs-Grade 4 |
3.323000E-03 |
| Grade 2-vs-Grade 3 |
2.216200E-04 |
| Grade 2-vs-Grade 4 |
6.30589999994768E-07 |
| Grade 3-vs-Grade 4 |
2.391600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.903100E-03 |
| Normal-vs-ccB subtype |
2.88479999888125E-08 |
| ccA subtype-vs-ccB subtype |
3.368700E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.5030000000047E-05 |
| Normal-vs-N1 |
1.363640E-03 |
| N0-vs-N1 |
2.264000E-01 |
|
|
